AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.
Also called NCT07555730
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT07555730
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07555730. Randomized; no masking; primary purpose treatment. Start 2026-04-30 (anticipated); primary completion 2028-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
- Condition
- Overweight or Obesity; Type 2 Diabetes
- Condition
- Weight Loss Maintenance
- Intervention (Behavioral)
- AI assisted multi-domain lifestyle intervention
- Intervention (Drug)
- Tirzepatide
- Lead sponsor
- Huazhong University of Science and Technology
Record details
- Record id
cardio:ct-nct07555730- Content hash
7c810c6645d1bc2ad66fa4cd8cbfeffaa528f305c57d904524b9a96e3d6a5784